FDA Getting Closer to Approving COVID-19 Vaccine for Kids 5 to 11
According to a report by the Washington Post, we're not too far away from seeing a coronavirus vaccine for the kids. Pfizer and BioNTech have finished their vaccine trials and have officially asked the Federal Drug Administration to authorize the vaccine for emergency use for children 5 to 11 years old.
Last month, Pfizer and BioNTech handed over their data to the FDA that recommended a regimen of two microgram doses of the vaccine for children which is one-third the amount given to adults.
In my opinion, if I had any children of my own in the 5 to 11-year-old range, I would get them vaccinated ASAP. No one needs to see their child in the hospital having difficulty breathing. I think it's just common sense. But some parents are not on board.
Pfizer and BioNTech announced stellar results from their September 20, 2021 trials where 2,268 children from 5 to 12 years of age took part. Scientists found the vaccine caused powerful neutralizing antibody responses using the two microgram doses.
The Washington Post reports that an FDA advisory committee will meet as soon as October 26 to examine all the data and officials have said its authorization may be given between Halloween and Thanksgiving.
Research from the C.S. Mott Children's Hospital National Poll found that across the country more than half of parents of children 3 to 11 said they most likely will not get their children vaccinated against COVID-19.
Here's something to think about. Healthcare professionals from the IU Fairbanks School for Public Health told The Atlantic, that, "Parents need to hear from their child’s doctor or other experts and peers from within their community that vaccinating against COVID-19 is a good thing. Up until now, most of the messages have come from media outlets, and that is not enough.”